Michael Lohmüller

4PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 30, 2024
Caspase-2 kills cells with extra centrosomes.

Dario Rizzotto, Vincenza Vigorito, Patricia Rieder

|Jan 20, 2023
A CRISPR screen in intestinal epithelial cells identifies novel factors for polarity and apical transport.

Katharina M C Klee, Michael W Hess, Michael Lohmüller

|Jun 08, 2022
The SKP2-p27 axis defines susceptibility to cell death upon CHK1 inhibition.

Michael Lohmüller, Bernhard F Roeck, Tamas G Szabo

|Oct 14, 2021
Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants.

André Volland, Michael Lohmüller, Emmanuel Heilmann

Pageof 1